Search the Newsreel

Liberty One Investment Management LLC Purchases 17,062 Shares of Colgate-Palmolive Company $CL

Liberty One Investment Management LLC has increased its stake in Colgate-Palmolive Company (NYSE:CL) by 33.3% during the first quarter, acquiring an additional 17,062 shares and bringing its total holdings to 68,358 shares valued at $5.83 million. Institutional ownership of Colgate-Palmolive remains high at 80.41%, …

Molina Healthcare stock trades steadily as Medicaid and marketplace growth support margins

Molina Healthcare's stock performance is supported by stable Medicaid membership and growing Affordable Care Act marketplace enrollment, with recent financial reports showing increased revenue and EPS. The company's focus on government-sponsored programs makes it sensitive to policy changes and contract renewals, but its disciplined …

Sei Investments Co. Buys 352,476 Shares of Colgate-Palmolive Company $CL

Sei Investments Co. increased its stake in Colgate-Palmolive (NYSE:CL) by 39.6% in the first quarter, acquiring an additional 352,476 shares, bringing its total holdings to 1,241,878 shares valued at approximately $105.8 million. This increase follows Colgate-Palmolive's better-than-expected quarterly results, with an EPS of $0.97 …

Molina Healthcare Posts Lower Profit, Revenue as Membership Declines

Molina Healthcare reported a significant drop in profit and revenue for its second quarter, with net income falling to $60 million from $255 million a year earlier. The decline was attributed to decreased membership, lower premium revenue, and an increase in the medical care …

Colgate-Palmolive stock trades near yearly high as earnings and dividend support valuation

Colgate-Palmolive stock is trading near its 52-week high, supported by consistent sales growth, strong operating margins, and a reliable dividend. The company's defensive profile is underscored by robust earnings and cash flow, which enable it to cover capital expenditures, dividends, and share repurchases. Its …

Colgate-Palmolive Company $CL Shares Bought by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership increased its stake in Colgate-Palmolive Company (NYSE:CL) by 2.3% in the first quarter, owning over 5.5 million shares worth $476 million. Other institutional investors like Kemnay Advisory Services Inc. and CBIZ Investment Advisory Services LLC also adjusted their holdings. The …

Molina Healthcare (MOH) Stock Confronts Volatile Margins After Q2 Profit And Trailing Loss

Colgate-Palmolive (CL) Earnings Expected to Grow: Should You Buy?

Colgate-Palmolive (CL) Expected to Post Quarterly Earnings on Friday

Colgate-Palmolive (CL) is projected to release its Q2 2026 earnings on Friday, July 31st, with analysts forecasting EPS of $0.947 and revenue of $5.356 billion. The company recently declared a quarterly dividend of $0.53 per share, yielding 2.4% annually, and has an average analyst …

Is UBS’s Q2 Outlook for Colgate (CL) Quietly Testing Its Emerging-Market Growth Narrative?

UBS analysts anticipate Colgate-Palmolive's Q2 results will align with consensus, driven by international operations and core segments, particularly ongoing momentum in emerging markets. This supports Colgate's long-term strategy of disciplined international expansion, highlighted by a recent dividend increase amidst cost pressures in key markets. …

Molina Healthcare Inc Stock 12‑Month Price Target Raised to $212.53, Implies 4% Downside

Molina Healthcare Inc's average price target has been raised slightly to $212.53 by 17 analysts, ranging from $142 to $286 per share. This new target suggests a 4% potential downside from its Jul. 22 closing price. The consensus rating from 23 analysts remains "Hold," …

Is Molina Healthcare Inc (MOH) a Bargain After 9.7% Drop? GF Val

Molina Healthcare Inc (MOH) shares recently fell 9.7% to $200.29, despite GuruFocus's GF Value™ indicating it is significantly undervalued with a potential upside of 50.6%. The company boasts a strong GF Score™ of 83/100, though its current P/E ratio is higher than its historical …

Molina Healthcare Inc (MOH) Q2 2026 Earnings Call Highlights: Strong Medicaid Performance Amid ...

Molina Healthcare Inc. (MOH) reported strong Q2 2026 results, with adjusted EPS of $1.51 and premium revenue of $10.2 billion, driven by robust Medicaid and improved Medicare performance. The company increased its full-year 2026 adjusted EPS guidance but faced challenges and reduced guidance for …

Colgate-Palmolive's Q2 Organic Sales Growth to Be Driven by Continued International Momentum, UBS Says

UBS projects that Colgate-Palmolive's second-quarter organic sales growth will be primarily fueled by ongoing international momentum. This outlook suggests strong performance in foreign markets will compensate for other factors, contributing positively to the company's overall sales figures for the quarter.

MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised

Molina Healthcare, Inc. MOH reported second-quarter 2026 adjusted earnings per share (EPS) of $1.51, which beat the Zacks Consensus Estimate by 10.2%. The bottom line declined 72.4% from the year-ago period's level. Revenues amounted to $10.9 billion, which decreased 4.8% year over year. The …

Molina Faces Very High Uncertainty Around a Range of Potential Profit Scenarios

Molina Healthcare, Inc. (MOH) is facing significant uncertainty regarding its future profit scenarios, according to a Morningstar analyst note published by Julie Utterback. The company specializes in at-risk medical insurance plans for government programs and focuses on managing medical and administrative costs. Morningstar had …

Form 10-Q MOLINA HEALTHCARE, INC. For: Jun 30

Molina Healthcare, Inc. filed its Form 10-Q for the quarter ended June 30, 2026, reporting a decrease in net income and operating income compared to the previous year, primarily due to lower premium revenue, an increased medical care ratio (MCR), and a $93 million …

HCA Healthcare earnings in focus as payer mix pressures mount

HCA Healthcare is poised to report second-quarter earnings, facing scrutiny despite beating revenue and earnings expectations due to concerns over worsening insurance coverage and patient volumes. The hospital operator pre-announced results, revealing a significant "payer mix shift" due to rising uninsured patients and subsequently …

Molina Healthcare Tops Q2 2026 Profit Forecast With $1.51 EPS

Molina Healthcare Inc. (NYSE:MOH) reported Q2 2026 adjusted earnings of $1.51 per share, surpassing the $1.40 consensus forecast by 7.9%. Despite beating profit expectations, the company experienced a 4.8% decline in revenue year-over-year, generating $10.87 billion, which led to a 6.3% drop in its …

Earnings call transcript: Molina Healthcare beats Q2 2026 EPS, shares fall premarket

Molina Healthcare reported stronger-than-expected Q2 2026 results with adjusted EPS of $1.51 and revenue of $10.87 billion, surpassing Wall Street estimates. Despite the beat, the company's shares fell 5.29% in premarket trading due to a weaker Marketplace outlook and other forward pressures, leading investors …

Are Options Traders Betting on a Big Move in Colgate-Palmolive Stock?

Options traders are showing increased activity in Colgate-Palmolive (CL) stock, particularly with the Aug. 21, 2026 $40 Call, which exhibits high implied volatility. While this suggests expectations of a significant price swing, analysts currently rate Colgate-Palmolive as a Zacks Rank #3 (Hold) with recent …

Molina Healthcare Releases Q2 2026 Financial Results

Molina Healthcare reported strong Q2 2026 results, with adjusted earnings of $1.51 per share, beating estimates by 7.9%. Despite a 4.8% decrease in revenue to $10.87 billion compared to Q2 2025, the company's Medicaid segment remained a key driver, contributing $8.05 billion. The managed …

Molina Healthcare Inc (MOH) approaches earnings with trend still active

The healthcare-plan operator has regained medium-term ground, but the latest weekly move shows some pressure before results.

Davis R M Inc. Lowers Holdings in Colgate-Palmolive Company $CL

Davis R M Inc. has reduced its stake in Colgate-Palmolive Company by 29.0% in the first quarter, selling 12,649 shares and leaving its holdings valued at $2.64 million. Despite this reduction by one firm, other institutional investors have recently increased their positions in Colgate-Palmolive, …

First Trust Advisors LP Sells 92,108 Shares of Colgate-Palmolive Company $CL

First Trust Advisors LP has reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 3.1% in the first quarter, selling 92,108 shares and now owning 2,904,290 shares valued at $247.53 million. Despite this, other institutional investors have increased their holdings, with 80.41% of the stock …

Molina Healthcare Earnings Beat Estimates. The Medicaid Insurer Is Confronting Investor Doubts. -- Barrons.com

Molina Healthcare reported first-quarter earnings that surpassed Wall Street expectations, with adjusted earnings per share of $5.92 against an estimated $5.68. The company is facing investor doubts regarding its medical cost trend in Medicaid and its future growth prospects. Despite these concerns, Molina affirmed …

Molina Healthcare shares fall after weak revenue outlook overshadows earnings beat (NYSE:MOH)

Molina Healthcare stock falls as first-half EPS covers 73.5% of 2026 floor

Molina Healthcare (NYSE:MOH) shares dropped 9.4% after hours despite an earnings beat and higher guidance, primarily because its first-half adjusted EPS of $3.86 already covers 73.5% of its $5.25 full-year floor for 2026, suggesting limited upside potential. The company's medical care ratio rose, driven …

Here's What Key Metrics Tell Us About Molina (MOH) Q2 Earnings

Molina (MOH) reported $10.87 billion in revenue for the quarter ended June 2026, representing a year-over-year decline of 4.8%. EPS of $1.51 for the same period compares to $5.48 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $10.88 billion, …

Molina (MOH) Q2 Earnings Top Estimates

Molina (MOH) came out with quarterly earnings of $1.51 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $5.48 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings …

Molina: Q2 Earnings Snapshot

Molina Healthcare Inc. reported a second-quarter profit of $60 million, or $1.19 per share. Adjusted earnings were $1.51 per share, surpassing Wall Street expectations of $1.37 per share. Despite missing revenue forecasts, the company projects full-year earnings of $5.25 per share.

Molina Healthcare slides nearly 7% on weak revenue outlook despite topping Q2 estimates

Molina Healthcare (NYSE:MOH) shares dropped nearly 7% after hours despite surpassing Q2 analyst expectations for earnings and revenue. The decline was driven by the company maintaining its full-year revenue guidance at $42 billion, significantly below the $44.28 billion analyst estimate. Although Molina raised its …

Earnings Flash (MOH) Molina Healthcare, Inc. Posts Q2 Adjusted EPS $1.51 per Share, vs. FactSet Est of $1.39

Molina Healthcare, Inc. (MOH) announced Q2 adjusted EPS of $1.51 per share, surpassing FactSet's estimate of $1.39. This financial update indicates a stronger-than-expected performance in earnings for the second quarter. The article also mentions the company's Q2 revenue of $10.87 billion, which also exceeded …

Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates

Healthcare plan provider Centene Corporation CNC is set to report second-quarter 2026 results on July 28, 2026, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at 89 cents per share on revenues of $47.53 billion. The …

Molina Healthcare earnings in focus as guidance decision looms

Molina Healthcare (NYSE: MOH) is set to report second-quarter earnings, with analysts anticipating a solid performance despite challenging year-over-year comparisons. The main focus for investors will be whether the Medicaid insurer will raise its full-year guidance, which currently stands at "at least $5.00 per …

Colgate-Palmolive Company $CL Shares Sold by Commerzbank Aktiengesellschaft FI

Commerzbank Aktiengesellschaft FI significantly reduced its stake in Colgate-Palmolive (NYSE:CL) by 29.9% in the first quarter, selling 14,490 shares and retaining 33,930 shares valued at approximately $2.89 million. Despite this sale, Colgate-Palmolive reported strong quarterly results, beating EPS and revenue expectations, and announced a …